Máj- és epeúti rák: vizsgálatok itt: Kanada
42 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Halifax, Montreal, Toronto
- Életkor
- 18 év and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - 1/2. fázisTaking peopleA Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- Where
- Montreal, Ottawa
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06428409 · EU 2023-508703-21-00 - 1/2. fázisTaking peopleBOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours
- Where
- Edmonton, Hamilton, Montreal, Ottawa, Toronto
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Bold Therapeutics, Inc.
See details and how to joinNCT04421820 · EU 2024-517500-11-00 - No phaseTaking peopleObservational Study Protocol: LIVER-R
- Where
- Calgary, Edmonton, Halifax, London
- Életkor
- 18 év to 130 év
- People
- 4000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06252753 - 3. fázisTaking peopleEfficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
- Where
- London, Montreal, Toronto
- Életkor
- 18 év and over
- People
- 286 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT06282575 · EU 2023-508219-21-00 - 3. fázisNot yet taking people in KanadaPersonalized Adaptive Radiotherapy for Hepatocellular Carcinoma
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 60
- Run by
- University Health Network, Toronto
See details and how to joinNCT07895732 - 1. fázisTaking peopleA First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
- Where
- Edmonton, Montreal, Sherbrooke, Toronto
- Életkor
- 18 év and over
- People
- 148 worldwide
- Run by
- Bayer
See details and how to joinNCT06764316 · EU 2024-516615-25-00 - 1. fázisTaking peopleSafety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 125 worldwide
- Run by
- Tyra Biosciences, Inc
See details and how to joinNCT06915753 - 3. fázisTaking peoplePhase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
- Where
- Brampton, Edmonton, Halifax, Montreal, Toronto
- Életkor
- 18 év to 99 év
- People
- 620 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06467357 · EU 2023-508057-19-00 - 3. fázisTaking peoplePhase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- Where
- Barrie, Brampton, Cambridge, Edmonton, Halifax, Montreal, Ottawa, Québec, Toronto
- Életkor
- 18 év and over
- People
- 1220 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06921785 · EU 2024-518210-81-00 - 4. fázisCsak meghívásosAtezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 24 worldwide
- Run by
- The Methodist Hospital Research Institute
See details and how to joinNCT05185505 - No phaseCsak meghívásosLiver Transplant for Stable, Advanced Intrahepatic Cholangiocarcinoma
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 10
- Run by
- University Health Network, Toronto
See details and how to joinNCT04195503 - 2. fázisTaking peopleAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Where
- Kingston, Montreal, Sherbrooke, Toronto
- Életkor
- 18 év and over
- People
- 226 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00 - 3. fázisTaking peopleA Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
- Where
- Barrie, Calgary, Halifax, Montreal, Québec, Toronto, Vancouver
- Életkor
- 18 év and over
- People
- 1100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07221253 · EU 2025-523085-24-00 - 2. fázisTaking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Montreal, Québec, Toronto
- Életkor
- 18 év to 130 év
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - No phaseTaking peopleViscoelasticity Imaging to Assess Liver Cancer
- Where
- Montreal
- Életkor
- 18 év and over
- People
- 200
- Run by
- Centre hospitalier de l'Université de Montréal (CHUM)
See details and how to joinNCT04409340 - 3. fázisTaking peopleRadiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma.
- Where
- Hamilton, London
- Életkor
- 18 év and over
- People
- 30
- Run by
- Hamilton Health Sciences Corporation
See details and how to joinNCT07027436 - 2. fázisTaking peopleStudy of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
- Where
- Kitchener, Montreal, Toronto
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT05727176 · EU 2023-503665-39-00 - 3. fázisTaking peopleTesting Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 226 worldwide
- Run by
- NRG Oncology
See details and how to joinNCT07166406 - 2. fázisTaking peopleSTRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma
- Where
- Calgary, Hamilton, Kelowna, Kingston, Kitchener, London, Mississauga, Montreal, Ottawa, Saskatoon, Toronto, Vancouver
- Életkor
- 18 év and over
- People
- 140
- Run by
- Canadian Cancer Trials Group
See details and how to joinNCT06880523 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Montreal, Toronto
- Életkor
- 8 év and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - 1. fázisTaking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Montreal, Toronto
- Életkor
- 18 év and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - No phaseTaking peopleDRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
- Where
- Hamilton, Montreal, Ottawa
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- Maastricht University Medical Center
See details and how to joinNCT07717437 - No phaseTaking peopleLANDscape MApping of Epitopes and T Cell Receptors for Selected Cancers
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 105
- Run by
- University Health Network, Toronto
See details and how to joinNCT04665388 - No phaseTaking peopleA Study of Standard Of Care Versus Radio Ablation in Early Stage HCC
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 218 worldwide
- Run by
- University Health Network, Toronto
See details and how to joinNCT07628751